Impact on balance sheet as at 31 December 2022 |
Note 25: Impact on balance sheet as at 1 January 2022 In accordance with the requirements of accounting standards, set out below is the Group’s balance sheet at 1 January 2022, prepared in accordance with the applicable accounting policies following the adoption of IFRS 17. Consolidated balance sheet – as at 1 January 2022 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Note | | As previously reported
At 31 Dec 2021 £m | | Impact of IFRS 17 (see below) £m | | Other changes (see note 1) £m | | | Restated
At 1 Jan 2022 £m | | | | | | | | | | | | | | | | Assets | | | | | | | | | | | | | | Cash and balances at central banks | | | 76,420 | | | | – | | | | – | | | | 76,420 | | | Items in the course of collection from banks | | | 147 | | | | – | | | | (147) | | | | | | Financial assets at fair value through profit or loss | 1 | | 206,771 | | | | 200 | | | | – | | | | 206,971 | | | Derivative financial instruments | | | 22,051 | | | | – | | | | – | | | | 22,051 | | | Financial assets at amortised cost | | | 517,156 | | | | – | | | | – | | | | 517,156 | | | Financial assets at fair value through other comprehensive income | | | 28,137 | | | | – | | | | – | | | | 28,137 | | | Reinsurance assets | 2 | | 759 | | | | (759) | | | | – | | | | | | Investments in joint ventures and associates | | | 352 | | | | – | | | | (352) | | | | | | Goodwill | | | 2,320 | | | | – | | | | (2,320) | | | | | | Value of in-force business | 3 | | 5,514 | | | | (5,317) | | | | (197) | | | | | | Other intangible assets | | | 4,196 | | | | – | | | | (4,196) | | | | | | Goodwill and other intangible assets | | | | | | – | | | | 6,713 | | | | 6,713 | | | Current tax recoverable | | | 363 | | | | – | | | | – | | | | 363 | | | Deferred tax assets | 4 | | 3,118 | | | | 655 | | | | – | | | | 3,773 | | | Retirement benefit assets | | | 4,531 | | | | – | | | | – | | | | 4,531 | | | Other assets | 2 | | 14,690 | | | | (47) | | | | 499 | | | | 15,142 | | | Total assets | | | 886,525 | | | | (5,268) | | | | – | | | | 881,257 | | |
NOTES TO THE CONDENSED CONSOLIDATED HALF-YEAR FINANCIAL STATEMENTS (continued) Note 25: Impact on balance sheet as at 1 January 2022 (continued) Consolidated balance sheet – as at 1 January 2022 (continued) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Note | | As previously reported
At 31 Dec 2021 £m | | Impact of IFRS 17 (see below) £m | | Other changes (see note 1) £m | | | Restated
At 1 Jan 2022 £m | | | | | | | | | | | | | | | | Liabilities | | | | | | | | | | | | | | Deposits from banks | | | 7,647 | | | | – | | | | – | | | | 7,647 | | | Customer deposits | | | 476,344 | | | | – | | | | – | | | | 476,344 | | | Repurchase agreements at amortised cost | | | 31,125 | | | | – | | | | – | | | | 31,125 | | | Items in course of transmission to banks | | | 316 | | | | – | | | | (316) | | | | | | Financial liabilities at fair value through profit or loss | | | 23,123 | | | | – | | | | – | | | | 23,123 | | | Derivative financial instruments | | | 18,060 | | | | – | | | | – | | | | 18,060 | | | Notes in circulation | | | 1,321 | | | | – | | | | – | | | | 1,321 | | | Debt securities in issue | | | 71,552 | | | | – | | | | – | | | | 71,552 | | | Liabilities arising from insurance contracts and participating investment contracts | 5 | | 123,423 | | | | 1,756 | | | | – | | | | 125,179 | | | Liabilities arising from non-participating investment contracts | 6 | | 45,040 | | | | (4,150) | | | | – | | | | 40,890 | | | Other liabilities | 7 | | 19,947 | | | | (896) | | | | 316 | | | | 19,367 | | | Retirement benefit obligations | | | 230 | | | | – | | | | – | | | | 230 | | | Current tax liabilities | | | 6 | | | | – | | | | – | | | | 6 | | | Deferred tax liabilities | 4 | | 39 | | | | (31) | | | | – | | | | 8 | | | Other provisions | | | 2,092 | | | | (12) | | | | – | | | | 2,080 | | | Subordinated liabilities | | | 13,108 | | | | – | | | | – | | | | 13,108 | | | Total liabilities | | | 833,373 | | | | (3,333) | | | | – | | | | 830,040 | | | | | | | | | | | | | | | | | Equity | | | | | | | | | | | | | | Share capital | | | 7,102 | | | | – | | | | – | | | | 7,102 | | | Share premium account | | | 18,479 | | | | – | | | | – | | | | 18,479 | | | Other reserves | | | 11,189 | | | | (12) | | | | – | | | | 11,177 | | | Retained profits | | | 10,241 | | | | (1,923) | | | | – | | | | 8,318 | | | Ordinary shareholders’ equity | | | 47,011 | | | | (1,935) | | | | – | | | | 45,076 | | | Other equity instruments | | | 5,906 | | | | – | | | | – | | | | 5,906 | | | Total equity excluding non-controlling interests | | | 52,917 | | | | (1,935) | | | | – | | | | 50,982 | | | Non-controlling interests | | | 235 | | | | – | | | | – | | | | 235 | | | Total equity | | | 53,152 | | | | (1,935) | | | | – | | | | 51,217 | | | Total equity and liabilities | | | 886,525 | | | | (5,268) | | | | – | | | | 881,257 | | |
1 Own shares held through consolidated collective investment vehicles classified as financial assets at fair value through profit or loss rather than in equity under IFRS 17. 2 Reinsurance assets are replaced by reinsurance contract assets, which are presented within other assets, under IFRS 17. 3 The value of in-force business (VIF) is not recognised on the balance sheet under IFRS 17 and acquired VIF presented within goodwill and other intangible assets. 4 Deferred tax assets and liabilities are recalculated based on IFRS 17 retained earnings. 5 Change in measurement basis of liabilities arising from insurance contracts and participating investment contracts under IFRS 17. 6 Recognition of certain hybrid unit-linked and With-Profit contracts under IFRS 17. 7 Unallocated surplus relating to the With-Profit funds is recognised as part of the liabilities arising from insurance contracts and participating investment contracts under IFRS 17. Note 26: Impact on income statement for the half-year ended 30 June 2022 The adjustments to the Group’s statutory income statement for the half-year ended 30 June 2022 arising on the adoption of IFRS 17 are presented below. Consolidated income statement for the half-year ended 30 June 2022 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Note | | As previously reported £m | | Impact of IFRS 17 (see below) £m | | Other changes (see note 1) £m | | | Restated £m | | | | | | | | | | | | | | | | Interest income | | | 7,429 | | | | – | | | | – | | | | 7,429 | | | Interest expense | 1 | | (229) | | | | – | | | | (1,163) | | | | (1,392) | | | Net interest income | | | 7,200 | | | | – | | | | (1,163) | | | | 6,037 | | | Fee and commission income | | | 1,408 | | | | (38) | | | | – | | | | 1,370 | | | Fee and commission expense | | | (662) | | | | 141 | | | | – | | | | (521) | | | Net fee and commission income | | | 746 | | | | 103 | | | | – | | | | 849 | | | Net trading income (losses) | | | (19,302) | | | | – | | | | – | | | | (19,302) | | | Insurance premium income | 2 | | 4,651 | | | | (4,651) | | | | – | | | | | | Insurance revenue | 3 | | | | | 1,201 | | | | – | | | | 1,201 | | | Insurance service expense | 4 | | | | | (1,447) | | | | – | | | | (1,447) | | | Net income (losses) from reinsurance contracts held | | | | | | (6) | | | | – | | | | (6) | | | Insurance service result | | | | | | (252) | | | | – | | | | (252) | | | Other operating income | 5 | | 385 | | | | 290 | | | | – | | | | 675 | | | Other income | | | (13,520) | | | | (4,510) | | | | – | | | | (18,030) | | | Total income | | | (6,320) | | | | (4,510) | | | | (1,163) | | | | (11,993) | | | Insurance claims and changes in insurance and investment contract liabilities | 6 | | 15,043 | | | | (15,043) | | | | – | | | | | | Net finance (expense) income from insurance, participating investment and reinsurance contracts | 7 | | | | | 14,300 | | | | – | | | | 14,300 | | | Movement in third party interests in consolidated funds | 1 | | | | | – | | | | 1,163 | | | | 1,163 | | | Change in non-participating investment contracts | 8 | | | | | 4,478 | | | | – | | | | 4,478 | | | Total income, after net finance (expense) income in respect of insurance and investment contracts | | | 8,723 | | | | (775) | | | | – | | | | 7,948 | | | Operating expenses | 9 | | (4,681) | | | | 263 | | | | – | | | | (4,418) | | | Impairment | | | (381) | | | | – | | | | – | | | | (381) | | | Profit before tax | | | 3,661 | | | | (512) | | | | – | | | | 3,149 | | | Tax expense | | | (835) | | | | 133 | | | | – | | | | (702) | | | Profit for the period | | | 2,826 | | | | (379) | | | | – | | | | 2,447 | | | | | | | | | | | | | | | | | Profit attributable to ordinary shareholders | | | 2,569 | | | | (379) | | | | – | | | | 2,190 | | | Profit attributable to other equity holders | | | 214 | | | | – | | | | – | | | | 214 | | | Profit attributable to equity holders | | | 2,783 | | | | (379) | | | | – | | | | 2,404 | | | Profit attributable to non-controlling interests | | | 43 | | | | – | | | | – | | | | 43 | | | Profit for the period | | | 2,826 | | | | (379) | | | | – | | | | 2,447 | | |
1 Movement in third party interests in consolidated funds is reclassified from interest expense to a separate line on the face of the income statement. 2 Insurance premium income is removed as this is no longer presented in the income statement under IFRS 17. 3 Insurance revenue includes the CSM released to the income statement and changes in the risk adjustment related to current service (for more details on IFRS 17 measurement see note 24). 4 Insurance services expense includes incurred claims excluding any investment components, attributable service expenses and losses as a result of contract modifications. 5 The change in operating income is primarily driven by the removal of the movement in the value of in-force asset. 6 These changes are analysed using different line items under IFRS 17. 7 Finance related changes to the carrying value of insurance, participating investment and reinsurance contracts. 8 Change in non-participating investment contracts is presented as a separate line item 9 Maintenance expenses are included within insurance service expense and acquisition expenses are deferred within the CSM under IFRS 17. Note 27: Impact on balance sheet as at 31 December 2022 The adjustments to the Group’s balance sheet as at 31 December 2022 arising on the adoption of IFRS 17 are presented below. Consolidated balance sheet – as at 31 December 2022 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Note | | As previously reported
At 31 Dec 2022 £m | | IFRS 17 adjustments as at 1 Jan 2022 (see below) £m | | IFRS 17 2022 movements £m | | Other changes (see note 1) £m | | | Restated
At 31 Dec 2022 £m | | | | | | | | | | | | | | | | | | | Assets | | | | | | | | | | | | | | | | | Cash and balances at central banks | | | 91,388 | | | | – | | | | – | | | | – | | | | 91,388 | | | Items in the course of collection from banks | | | 242 | | | | – | | | | – | | | | (242) | | | | | | Financial assets at fair value through profit or loss | 1 | | 180,609 | | | | 200 | | | | (40) | | | | – | | | | 180,769 | | | Derivative financial instruments | | | 24,753 | | | | – | | | | – | | | | – | | | | 24,753 | | | Financial assets at amortised cost | | | 520,322 | | | | – | | | | – | | | | – | | | | 520,322 | | | Financial assets at fair value through other comprehensive income | | | 23,154 | | | | – | | | | – | | | | – | | | | 23,154 | | | Reinsurance assets | 2 | | 616 | | | | (759) | | | | 143 | | | | – | | | | | | Investments in joint ventures and associates | | | 385 | | | | – | | | | – | | | | (385) | | | | | | Goodwill | | | 2,655 | | | | – | | | | – | | | | (2,655) | | | | | | Value of in-force business | 3 | | 5,419 | | | | (5,317) | | | | 72 | | | | (174) | | | | | | Other intangible assets | | | 4,786 | | | | – | | | | – | | | | (4,786) | | | | | | Goodwill and other intangible assets | | | | | | – | | | | – | | | | 7,615 | | | | 7,615 | | | Current tax recoverable | | | 612 | | | | – | | | | – | | | | – | | | | 612 | | | Deferred tax assets | 4 | | 5,228 | | | | 655 | | | | 539 | | | | – | | | | 6,422 | | | Retirement benefit assets | | | 3,823 | | | | – | | | | – | | | | – | | | | 3,823 | | | Other assets | 2 | | 13,837 | | | | (47) | | | | 119 | | | | 627 | | | | 14,536 | | | Total assets | | | 877,829 | | | | (5,268) | | | | 833 | | | | – | | | | 873,394 | | |
NOTES TO THE CONDENSED CONSOLIDATED HALF-YEAR FINANCIAL STATEMENTS (continued) Note 27: Impact on balance sheet as at 31 December 2022 (continued) Consolidated balance sheet – as at 31 December 2022 (continued) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Note | | As previously reported
At 31 Dec 2022 £m | | IFRS 17 adjustments as at 1 Jan 2022 (see below) £m | | IFRS 17 2022 movements £m | | Other changes (see note 1) £m | | | Restated
At 31 Dec 2022 £m | | | | | | | | | | | | | | | | | | | Liabilities | | | | | | | | | | | | | | | | | Deposits from banks | | | 7,266 | | | | – | | | | – | | | | – | | | | 7,266 | | | Customer deposits | | | 475,331 | | | | – | | | | – | | | | – | | | | 475,331 | | | Repurchase agreements at amortised cost | | | 48,596 | | | | – | | | | – | | | | – | | | | 48,596 | | | Items in course of transmission to banks | | | 372 | | | | – | | | | – | | | | (372) | | | | | | Financial liabilities at fair value through profit or loss | | | 17,755 | | | | – | | | | – | | | | – | | | | 17,755 | | | Derivative financial instruments | | | 24,042 | | | | – | | | | – | | | | – | | | | 24,042 | | | Notes in circulation | | | 1,280 | | | | – | | | | – | | | | – | | | | 1,280 | | | Debt securities in issue | | | 73,819 | | | | – | | | | – | | | | – | | | | 73,819 | | | Liabilities arising from insurance contracts and participating investment contracts | 5 | | 106,893 | | | | 1,756 | | | | 1,629 | | | | – | | | | 110,278 | | | Liabilities arising from non-participating investment contracts | 6 | | 42,975 | | | | (4,150) | | | | 651 | | | | – | | | | 39,476 | | | Other liabilities | 7 | | 19,090 | | | | (896) | | | | 198 | | | | 372 | | | | 18,764 | | | Retirement benefit obligations | | | 126 | | | | – | | | | – | | | | – | | | | 126 | | | Current tax liabilities | | | 8 | | | | – | | | | – | | | | – | | | | 8 | | | Deferred tax liabilities | 4 | | 216 | | | | (31) | | | | 24 | | | | – | | | | 209 | | | Other provisions | | | 1,809 | | | | (12) | | | | 6 | | | | – | | | | 1,803 | | | Subordinated liabilities | | | 10,730 | | | | – | | | | – | | | | – | | | | 10,730 | | | Total liabilities | | | 830,308 | | | | (3,333) | | | | 2,508 | | | | – | | | | 829,483 | | | | | | | | | | | | | | | | | | | | Equity | | | | | | | | | | | | | | | | | Share capital | | | 6,729 | | | | – | | | | – | | | | – | | | | 6,729 | | | Share premium account | | | 18,504 | | | | – | | | | – | | | | – | | | | 18,504 | | | Other reserves | | | 6,602 | | | | (12) | | | | (3) | | | | – | | | | 6,587 | | | Retained profits | | | 10,145 | | | | (1,923) | | | | (1,672) | | | | – | | | | 6,550 | | | Ordinary shareholders’ equity | | | 41,980 | | | | (1,935) | | | | (1,675) | | | | – | | | | 38,370 | | | Other equity instruments | | | 5,297 | | | | – | | | | – | | | | – | | | | 5,297 | | | Total equity excluding non-controlling interests | | | 47,277 | | | | (1,935) | | | | (1,675) | | | | – | | | | 43,667 | | | Non-controlling interests | | | 244 | | | | – | | | | – | | | | – | | | | 244 | | | Total equity | | | 47,521 | | | | (1,935) | | | | (1,675) | | | | – | | | | 43,911 | | | Total equity and liabilities | | | 877,829 | | | | (5,268) | | | | 833 | | | | – | | | | 873,394 | | |
1 Own shares held through consolidated collective investment vehicles classified as financial assets at fair value through profit or loss rather than in equity under IFRS 17. 2 Reinsurance assets are replaced by reinsurance contract assets, which are presented within other assets, under IFRS 17. 3 The value of in-force business (VIF) is not recognised on the balance sheet under IFRS 17 and acquired VIF presented within goodwill and other intangible assets. 4 Deferred tax assets and liabilities are recalculated based on IFRS 17 retained earnings. 5 Change in measurement basis of liabilities arising from insurance contracts and participating investment contracts under IFRS 17. 6 Recognition of certain hybrid unit-linked and With-Profit contracts under IFRS 17. 7 Unallocated surplus relating to the With-Profit funds is recognised as part of the liabilities arising from insurance contracts and participating investment contracts under IFRS 17.
|